TrialLeukemia research2013

Phase I clinical, pharmacokinetic, and pharmacodynamic study of the Akt-inhibitor triciribine phosphate monohydrate in patients with advanced hematologic malignancies.

Deepa Sampath et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.